MOHC recognizes the significant challenges of navigating a cancer diagnosis and is committed to providing you with the most advanced and personalized cancer care.
Depending on your medical condition, you may be offered participation in a clinical trial. The purpose of these studies is to provide our patients with access to the latest investigational treatments as quickly and safely as possible. This can ultimately lead to the introduction of new therapies to the wider patient population. MOHC is dedicated to improving patient outcomes by actively seeking new and improved treatment options through research.
Ask your Provider if you may benefit from a clinical trial!
Medical Oncology Hematology Consultants is an established research leader in communities throughout Delaware and offers clinical trials through Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials. SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today.
Our Affiliations
Clinical trials are available at our office through the Christiana Care NCORP. The Helen F. Graham Cancer Center’s NCORP is a National Cancer Institute (NCI) – appointed member of the NCI Community Cancer Center Program, funding 60 programs to improve aspects of community cancer care and research.
Trials are also available through various pharmaceutical companies, in addition to NCORP and SCRI programs. Collectively, over 125 studies are generally available at any given point in time.
Medical Oncology Hematology Consultants is also the proud recipient of the 2008 American Society of Clinical Oncology (ASCO) Clinical Trials Participation Award. Our practice is one of ten community oncology practices selected for this distinctive award.